Sunshine Biopharma, Inc.
SBFM
$1.40
-$0.02-1.41%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -10.45% | -52.99% | -40.55% | -35.23% | -41.67% |
| Total Receivables | -9.71% | 21.84% | 51.56% | 58.24% | 97.56% |
| Inventory | 53.33% | 54.03% | 96.66% | 117.42% | 99.74% |
| Prepaid Expenses | -47.12% | 12.86% | 264.87% | 1,856.91% | 1,560.28% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 8.17% | -15.09% | 4.32% | 2.15% | -1.34% |
|
|
|||||
| Total Current Assets | 8.17% | -15.09% | 4.32% | 2.15% | -1.34% |
| Net Property, Plant & Equipment | 38.53% | 41.80% | 46.37% | 13.32% | 2.56% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 1.79% | 54.59% | 109.08% | 141.96% | 98.37% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 9.09% | -8.50% | 11.75% | 8.70% | 3.14% |
|
|
|||||
| Total Accounts Payable | -2.69% | 38.98% | 114.39% | 87.19% | 180.15% |
| Total Accrued Expenses | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 94.32% | 85.44% | 75.06% | -1.27% | -6.22% |
| Total Finance Division Other Current Liabilities | 117.25% | -81.31% | -80.19% | -90.73% | -90.82% |
| Total Other Current Liabilities | 117.25% | -81.31% | -80.19% | -90.73% | -90.82% |
| Total Current Liabilities | 5.18% | -11.80% | 13.75% | -11.00% | 13.72% |
|
|
|||||
| Total Current Liabilities | 5.18% | -11.80% | 13.75% | -11.00% | 13.72% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 52.62% | 45.31% | 38.16% | -20.77% | -22.45% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 13.26% | 13.26% |
| Total Liabilities | 8.08% | -8.40% | 14.98% | -11.77% | 9.64% |
|
|
|||||
| Common Stock & APIC | 8.39% | 4.31% | 10.59% | 8.68% | 6.39% |
| Retained Earnings | -9.60% | -7.72% | -8.03% | -6.74% | -5.93% |
| Treasury Stock & Other | 141.11% | -627.43% | -219.24% | -17.56% | -202.71% |
| Total Common Equity | 9.35% | -8.53% | 10.76% | 13.95% | 1.59% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 0.00% | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00% | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% |
|
|
|||||
| Total Common Equity | 9.35% | -8.53% | 10.76% | 13.95% | 1.59% |
| Total Preferred Equity | 0.00% | 0.00% | 1,200.00% | 1,200.00% | 1,200.00% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 9.34% | -8.53% | 10.81% | 14.00% | 1.64% |
|
|
|||||